Andy Moye

Andy Moye is the current Chief Executive Officer at Paige. Prior to that, they served as the Vice President Of Business Development for Life Sciences at Ontada from October 2020 to March 2021. Andy has also held various other positions at companies such as Philips, WaferGen, and CombiMatrix.

Andy has always been driven by their passion for helping others. This was evident early on in their career when they worked as a sales representative for a pharmaceutical company. Andy quickly rose through the ranks and eventually became the Global Vice President of Sales for WaferGen. In this role, they were responsible for leading a team of sales professionals and driving growth for the company.

After a few years in the industry, Andy decided to make a change and transitioned into the world of business development. Andy joined CombiMatrix as the Vice-President of Business Development, Sales, and Strategy in 2013. In this role, they were responsible for developing and executing the company’s sales and marketing strategy. Andy helped grow the company significantly during their tenure and played a key role in its eventual sale to Philips in 2017.

Andy is a strategic thinker with a proven track record of success in the life sciences industry. Andy is passionate about helping others and making a difference in the fight against cancer.

Andy Moye's educational career began with a Bachelor of Science in Physiology from the University of Arizona. Andy then went on to earn a Master of Business Administration from the University of Florida - Warrington College of Business. Most recently, they have completed a Doctor of Philosophy in Health Economics from Walden University.

Some direct reports include Christina Segro - Corporate Counsel, Juan Retamero - Medical Director, and Peter Hamilton - Chief Operational Officer.